Carna Biosciences Inc (4572)

Currency in JPY
226.0
-80.0(-26.14%)
Closed·
4572 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
4572 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
226.0253.0
52 wk Range
220.0482.0
Key Statistics
Bid/Ask
226.00 / 226.00
Prev. Close
306
Open
234
Day's Range
226-253
52 wk Range
220-482
Volume
3.05M
Average Volume (3m)
186.01K
1-Year Change
-22.64%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4572 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Carna Biosciences Inc Company Profile

Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, Luciferase PPI stable cell lines, kinase assay kits, peptide substrate, mobility shifty assay, and lipid kinase panels. The company also offers profiling, NanoBRET TE intracellular kinase cell-based assay, protein detection assays. It also focuses on developing products for the treatment of various diseases, such as AS-0141, an orally bioavailable small molecule inhibitor of CDC7 kinase that is in preclinical trials to treat cancer; AS-0871, a small molecule drug for inflammatory and immune disorders, which is in Phase 1 clinical trials; and AS-1763, an orally bioavailable and non-covalent inhibitor for the treatment of chronic lymphocytic leukemia and other B cell malignancies that is in preclinical trials. The company has collaborations with Sumitomo Pharma, Gilead Sciences. Carna Biosciences, Inc. was incorporated in 2003 and is based in Kobe, Japan.

Compare 4572 to Peers and Sector

Metrics to compare
4572
Peers
Sector
Relationship
P/E Ratio
−2.7x−0.9x−0.5x
PEG Ratio
0.030.050.00
Price/Book
3.1x1.6x2.6x
Price / LTM Sales
10.2x1.6x3.3x
Upside (Analyst Target)
-81.5%43.4%
Fair Value Upside
Unlock23.3%7.1%Unlock

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

4572 Income Statement

FAQ

What Stock Exchange Does Carna Biosciences Trade On?

Carna Biosciences is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Carna Biosciences?

The stock symbol for Carna Biosciences is "4572."

What Is the Carna Biosciences Market Cap?

As of today, Carna Biosciences market cap is 4.49B.

What Is Carna Biosciences's Earnings Per Share (TTM)?

The Carna Biosciences EPS (TTM) is -113.77.

When Is the Next Carna Biosciences Earnings Date?

Carna Biosciences will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is 4572 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Carna Biosciences Stock Split?

Carna Biosciences has split 1 times.

How Many Employees Does Carna Biosciences Have?

Carna Biosciences has 63 employees.

What is the current trading status of Carna Biosciences (4572)?

As of 08 Aug 2025, Carna Biosciences (4572) is trading at a price of 226.00, with a previous close of 306.00. The stock has fluctuated within a day range of 226.00 to 253.00, while its 52-week range spans from 220.00 to 482.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.